Nuveen LLC acquired a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 3,858,156 shares of the financial services provider's stock, valued at approximately $715,765,000. Nuveen LLC owned approximately 0.80% of Marsh & McLennan Companies at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC grew its stake in Marsh & McLennan Companies by 51.2% during the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider's stock valued at $1,856,000 after acquiring an additional 2,960 shares in the last quarter. Bison Wealth LLC grew its stake in Marsh & McLennan Companies by 39.6% during the fourth quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider's stock valued at $651,000 after acquiring an additional 869 shares in the last quarter. Glenview Trust co grew its stake in Marsh & McLennan Companies by 10.8% during the second quarter. Glenview Trust co now owns 3,897 shares of the financial services provider's stock valued at $852,000 after acquiring an additional 379 shares in the last quarter. Osterweis Capital Management Inc. grew its stake in Marsh & McLennan Companies by 18,440.0% during the second quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider's stock valued at $203,000 after acquiring an additional 922 shares in the last quarter. Finally, Diversify Advisory Services LLC purchased a new position in Marsh & McLennan Companies during the second quarter valued at $1,307,000. 87.99% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Marsh & McLennan Companies
In related news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the transaction, the chief executive officer directly owned 116,811 shares of the company's stock, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages have commented on MRSH. JPMorgan Chase & Co. dropped their price objective on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an "overweight" rating for the company in a research note on Thursday, April 9th. UBS Group dropped their price objective on shares of Marsh & McLennan Companies from $230.00 to $203.00 and set a "buy" rating for the company in a research note on Tuesday. Weiss Ratings cut shares of Marsh & McLennan Companies from a "hold (c)" rating to a "hold (c-)" rating in a research note on Monday, May 11th. Keefe, Bruyette & Woods lifted their price objective on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a "market perform" rating in a research note on Friday, April 17th. Finally, Barclays dropped their price objective on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an "overweight" rating for the company in a research note on Wednesday, April 8th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $200.19.
Check Out Our Latest Analysis on MRSH
Marsh & McLennan Companies Stock Up 0.6%
MRSH stock opened at $168.20 on Friday. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $220.32. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. The stock has a market cap of $81.26 billion, a P/E ratio of 21.02, a PEG ratio of 2.43 and a beta of 0.62.
Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last released its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, topping analysts' consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The firm had revenue of $7.30 billion during the quarter. The firm's revenue was up 7.6% on a year-over-year basis. As a group, research analysts forecast that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current fiscal year.
Marsh & McLennan Companies Company Profile
(
Free Report)
Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Stories
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.